Clindamycin Phosphate Prices, Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data Report 2026 Edition
Clindamycin Phosphate Price Trend, Index and Forecast
Track the latest insights on clindamycin phosphate price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Clindamycin Phosphate Prices Outlook Q2 2026
- USA: USD 177128/MT
- China: USD 143216/MT
- Germany: USD 161346/MT
- India: USD 168202/MT
- Brazil: USD 207196/MT
Clindamycin Phosphate Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the second quarter of 2026, the clindamycin phosphate prices in the USA reached 177128 USD/MT. Prices rose as strong demand from the medical field and increased raw material costs supported market activity. Clindamycin phosphate maintained significant importance within the antibiotic market, sustaining consumption. Higher logistics costs further encouraged elevated pricing levels.
During the second quarter of 2026, the clindamycin phosphate prices in China reached 143216 USD/MT in June. Prices increased strongly as higher production expenses and strict environmental regulations supported producer offers. Pharmaceutical manufacturers maintained steady procurement for antibiotic formulations, supporting available inventories through the market. Port congestion and changing shipping conditions periodically limited prompt cargo movement and increased replacement uncertainty.
During the second quarter of 2026, the clindamycin phosphate prices in Germany reached 161346 USD/MT in June. Prices moved upward as tighter delivered supply and stronger export enquiries supported the European market. Logistics disruptions and port congestion restricted the timely movement of material, which increased replacement concerns among pharmaceutical companies. Demand in the medical sector remained supportive, particularly for treating bacterial infections, sustaining market dynamics.
During the second quarter of 2026, the clindamycin phosphate prices in India reached 168202 USD/MT. Prices increased as Asian supply tightened and replacement costs rose across the pharmaceutical chain. Indian buyers faced firmer regional offers as strong domestic and international demand absorbed available volumes and reduced prompt market flexibility. Requirements from the healthcare sector supported steady procurement.
During the second quarter of 2026, the clindamycin phosphate prices in Brazil reached 207196 USD/MT. Prices recorded a moderate increase due to imported raw material and replacement costs remaining firm during much of the quarter. Regional shipping constraints, port congestion, and higher insurance expenses affected cargo availability, encouraging buyers to secure material for planned pharmaceutical production. Demand from the healthcare and antibiotic sectors provided a stable consumption base.
Clindamycin Phosphate Prices Outlook Q3 2025
- USA: USD 160561/MT
- China: USD 140163/MT
- Germany: USD 157767/MT
- India: USD 164804/MT
- Brazil: USD 195200/MT
During the third quarter of 2025, the clindamycin phosphate prices in the USA reached 160561 USD/MT in September. Prices increased as demand from pharmaceutical formulation and hospital supply chains remained firm. Producers operated with controlled output amid high regulatory compliance costs, while buyers prioritized supply security for finished dosage manufacturing. Limited availability of alternative suppliers supported procurement at higher negotiated levels.
During the third quarter of 2025, the clindamycin phosphate prices in China reached 140163 USD/MT in September. Prices declined due to softer export demand and adequate domestic supply availability. API manufacturers maintained stable production levels, while overseas buyers delayed procurement amid inventory sufficiency. Competitive pricing pressure from regional suppliers influenced trade negotiations.
During the third quarter of 2025, the clindamycin phosphate prices in Germany reached 157767 USD/MT in September. Prices moved lower as demand from downstream pharmaceutical processors moderated. Buyers adopted cautious sourcing strategies, focusing on contractual volumes rather than spot purchases. Adequate supply availability and competitive import options shaped procurement behavior across the market.
During the third quarter of 2025, the clindamycin phosphate prices in India reached 164804 USD/MT in September. Prices increased supported by strong demand from export-oriented pharmaceutical manufacturers. API producers benefited from steady international orders, while controlled production schedules and compliance-related costs influenced supply availability. Buyers emphasized long-term sourcing arrangements to ensure continuity.
During the third quarter of 2025, the clindamycin phosphate prices in Brazil reached 195200 USD/MT in September. Prices rose due to sustained demand from domestic pharmaceutical formulation units and reliance on imports. Supply chain lead times and regulatory requirements influenced procurement planning, while buyers focused on securing consistent volumes for essential medicine production.
Clindamycin Phosphate Prices Outlook Q2 2025
- USA: USD 156340/MT
- China: USD 143170/MT
- Germany: USD 162982/MT
- India: USD 159078/MT
- Brazil: USD 187152/MT
During the second quarter of 2025, the clindamycin phosphate prices in the USA reached 156340 USD/MT in June. Market activity was shaped by consistent demand from pharmaceutical formulation units and hospital supply chains. Buyers focused on structured procurement aligned with production schedules, while producers maintained output discipline to meet regulatory and quality requirements. Inventory planning and supplier qualification remained central considerations for formulators.
During the second quarter of 2025, the clindamycin phosphate prices in China reached 143170 USD/MT in June. Demand from export-oriented pharmaceutical manufacturers followed routine ordering cycles. Producers operated with adequate capacity, while buyers emphasized documentation, compliance standards, and shipment reliability. Procurement decisions were influenced by regulatory approvals and alignment with international customer requirements.
During the second quarter of 2025, the clindamycin phosphate prices in Germany reached 162982 USD/MT in June. Pharmaceutical processors sourced material based on validated supplier relationships and quality certifications. Buyers prioritized consistency and traceability, while suppliers ensured uninterrupted availability to support regulated manufacturing operations. Demand followed planned formulation schedules rather than spot-market activity.
During the second quarter of 2025, the clindamycin phosphate prices in India reached 159078 USD/MT in June. API manufacturers focused on meeting export commitments and maintaining compliance with regulated market standards. Buyers engaged in scheduled procurement tied to shipment planning, while producers managed capacity utilization to support steady international supply obligations.
During the second quarter of 2025, the clindamycin phosphate prices in Brazil reached 187152 USD/MT in June. Market conditions reflected import-dependent sourcing and procurement by domestic pharmaceutical formulators. Buyers emphasized supply continuity, regulatory documentation, and lead-time management, while distributors coordinated logistics to meet production timelines for finished dosage manufacturing.
Regional Coverage
The report provides a detailed analysis of the clindamycin phosphate market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast, and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing clindamycin phosphate prices.
Europe Clindamycin Phosphate Price Trend
Q2 2026:
The clindamycin phosphate price index in Europe moved upward as tighter delivered supply, export demand, and logistics constraints supported firmer offers. Port congestion periodically restricted shipments and raised replacement concerns among pharmaceutical manufacturers. Production pressure, even when feedstock costs eased later in the quarter, kept prices supported. Demand from pharmaceutical preparations, particularly antibiotics, provided consistent support. German manufacturing plants continued operating reliably, maintaining supply continuity and preventing a more severe shortage. Buyers generally purchased against immediate requirements due to comfortable inventory levels in several markets. Export orders absorbed part of the available material, reducing downward pricing pressure.
Q3 2025:
As per the clindamycin phosphate price index, Europe recorded lower prices, driven by declines in Germany alongside broader softening across regional pharmaceutical procurement channels. Demand from formulation units eased as production schedules normalized, leading buyers to rely more heavily on contractual volumes. Regulatory compliance, audit readiness, and supplier qualification remained central to sourcing decisions. Producers focused on maintaining validated supply chains, while import availability and documentation requirements influenced cross-border procurement across the region.
Q2 2025:
Europe’s market conditions were shaped by procurement behavior across multiple regulated pharmaceutical markets. Demand from formulation units followed planned manufacturing cycles, with buyers emphasizing supplier consistency, pharmacopoeia compliance, and traceability. Producers ensured uninterrupted availability to meet regulatory obligations, while sourcing strategies reflected coordination between domestic production and approved import channels rather than shifts in consumption intensity.
This analysis can be extended to include detailed clindamycin phosphate price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Clindamycin Phosphate Price Trend
Q2 2026:
The clindamycin phosphate price index in North America rose strongly as constrained prompt availability and active pharmaceutical demand tightened market balances. Pharmaceutical formulations and antibiotics supported steady procurement. Export demand absorbed regional volumes and reduced spot flexibility, strengthening seller negotiating power. Feedstock and raw material costs also increased production pressure during much of the quarter. Logistics difficulties and higher insurance and transportation costs added further support to replacement values. Concerns about the supply chain encouraged buyers to protect inventories and continue regular purchasing instead of delaying orders. Producers kept offers firm as domestic availability remained relatively tight.
Q3 2025:
As per the clindamycin phosphate price index, North America posted higher prices, led by increases in the USA. Demand from branded and generic drug manufacturers remained firm, particularly for hospital-administered antibiotics. Buyers prioritized supply security and regulatory alignment, while producers managed output within stringent quality frameworks. Procurement strategies emphasized long-term agreements and validated supplier relationships to ensure continuity for essential formulations.
Q2 2025:
North America’s market environment reflected structured procurement activity across pharmaceutical manufacturers. Buyers focused on inventory planning, regulatory documentation, and compliance with Good Manufacturing Practice standards. Producers aligned output with confirmed formulation requirements, while distributors coordinated logistics to support uninterrupted supply to downstream drug manufacturing facilities.
Specific clindamycin phosphate historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Clindamycin Phosphate Price Trend
Q2 2026:
The study includes clindamycin phosphate price trends across the Middle East and Africa, considering variables that have a direct impact on market prices, such as regional industrial expansion, natural resource availability, and geopolitical conflicts.
Q3 2025:
As per clindamycin phosphate price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the clindamycin phosphate pricing trends and clindamycin phosphate price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on clindamycin phosphate prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Clindamycin Phosphate Price Trend
Q2 2026:
Clindamycin phosphate prices in Asia Pacific moved upward as higher feedstock costs, logistics pressure, and steady pharmaceutical demand supported the market. China experienced restricted prompt availability and firmer production economics during much of the quarter, while port congestion and shipping conditions periodically constrained cargo movement. Japan also faced elevated import replacement costs and freight uncertainty, encouraging buyers to maintain scheduled procurement. Demand from healthcare applications, particularly for bacterial infection treatments, provided a stable consumption base across the region. Producers maintained disciplined offers as input costs remained elevated.
Q3 2025:
In the Asia Pacific region, clindamycin phosphate prices showed mixed movement, with increases in India and declines in China. In India, export-oriented demand from regulated markets supported procurement interest, while producers operated within controlled capacity frameworks. In China, softer overseas demand and sufficient domestic availability influenced buyer behavior. Across the region, regulatory approvals, audit schedules, and documentation requirements played a critical role in shaping trade flows.
Q2 2025:
Clindamycin phosphate market dynamics were defined by export-driven production and structured sourcing across major manufacturing hubs. Buyers aligned procurement with shipment schedules and regulatory clearances, while producers focused on maintaining compliance with international quality standards. Supply planning emphasized audit readiness, documentation accuracy, and coordination with global pharmaceutical customers rather than volume-driven purchasing.
This clindamycin phosphate price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Clindamycin Phosphate Price Trend
Q2 2026:
The clindamycin phosphate prices across Latin America moved upward as steady pharmaceutical demand, import dependence, and higher sourcing expenses supported firmer market conditions. Procurement remained stable from pharmaceutical manufacturers producing injectable and topical antibiotic formulations, helping absorb available inventories. Limited regional production of pharmaceutical grade material increased dependence on imports, exposing buyers to international supply conditions, freight expenses, and longer replenishment schedules. Higher costs for pharmaceutical intermediates, processing, quality control, and regulatory compliance also placed pressure on replacement values. Logistics constraints and transportation expenses further increased delivered costs across major consuming markets.
Q3 2025:
In Latin America, clindamycin phosphate prices increased, led by higher prices in Brazil. Demand from domestic pharmaceutical formulation units remained consistent, supported by reliance on imports. Buyers emphasized supplier reliability, regulatory compliance, and lead-time management. Distributors coordinated logistics and documentation to ensure uninterrupted supply for essential medicine production.
Q2 2025:
Market conditions were shaped by import-dependent sourcing and routine procurement by pharmaceutical manufacturers across the region. Buyers focused on continuity of supply, regulatory approvals, and alignment with formulation schedules. Inventory planning reflected lead times and storage requirements, while distributors managed logistics to meet consistent downstream manufacturing needs.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Clindamycin Phosphate Pricing Report, Market Analysis, and News
IMARC's latest publication, “Clindamycin Phosphate Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the clindamycin phosphate market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of clindamycin phosphate at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed clindamycin phosphate prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting clindamycin phosphate pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Clindamycin Phosphate Industry Analysis
The global clindamycin phosphate market size reached USD 872.6 Million in 2025. By 2034, IMARC Group expects the market to reach USD 1352.0 Million, at a projected CAGR of 4.98% during 2026-2034. The market is primarily driven by the rising demand for effective antibacterial treatments, increasing use in healthcare settings, and the need for pharmaceuticals with strong infection fighting capabilities.
Latest News and Developments:
- February 2025: Glenmark Pharmaceuticals Inc., USA announced the commercial launch of Clindamycin Phosphate Foam, 1% for the treatment of acne, marking a strategic expansion of its dermatology product portfolio in the U.S. generics market. The newly launched foam product is bioequivalent and therapeutically equivalent to the reference listed drug Evoclin Foam, 1% previously marketed by Mylan Pharmaceuticals Inc., and aims to provide dermatologists and patients with an effective antibiotic foam option for acne management.
Product Description
Clindamycin phosphate is a semisynthetic antibiotic derivative of clindamycin, which is related to lincomycin originally produced by Streptomyces lincolnensis. It belongs to the lincosamide class of antibiotics and works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. Clindamycin phosphate is a phosphate ester prodrug that is converted in the body to active clindamycin. It is particularly effective against many Gram positive and anaerobic bacteria and is used in the treatment of susceptible bacterial infections. Its water solubility makes it suitable for pharmaceutical formulations such as injections, topical solutions, gels, lotions, and certain vaginal preparations. Clindamycin based medicines are used for skin and soft tissue infections, bone and joint infections, dental infections, and other susceptible bacterial infections. Clindamycin phosphate is also used in selected veterinary pharmaceutical applications.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Clindamycin Phosphate |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Clindamycin Phosphate Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of clindamycin phosphate pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting clindamycin phosphate price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clindamycin phosphate price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Related Reports
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.